Abstract:Background Previous studies on European (EUR) samples have obtained inconsistent results regarding the genetic correlation between type 2 diabetes mellitus (T2DM) and Schizophrenia (SCZ). A large-scale trans-ethnic genetic analysis may provide additional evidence with enhanced power. Objective We aimed to explore the genetic basis for both T2DM and SCZ based on large-scale genetic analyses of genome-wide association study (GWAS) data from both East Asian (EAS) and EUR subjects. Methods A range of complementary approaches were employed to cross-validate the genetic correlation between T2DM and SCZ at the whole genome, autosomes (linkage disequilibrium score regression, LDSC), loci (Heritability Estimation from Summary Statistics, HESS), and causal variants (MiXeR and Mendelian randomization, MR) levels. Then, genome-wide and transcriptome-wide cross-trait/ethnic meta-analyses were performed separately to explore the effective shared organs, cells and molecular pathways. Results A weak genome-wide negative genetic correlation between SCZ and T2DM was found for the EUR (r g = − 0.098, P = 0.009) and EAS (r g =- 0.053 and P = 0.032) populations, which showed no significant difference between the EUR and EAS populations ( P = 0.22). After Bonferroni correction, the r g remained significant only in the EUR population. Similar results were obtained from analyses at the levels of autosomes, loci and causal variants. 25 independent variants were firstly identified as being responsible for both SCZ and T2DM. The variants associated with the two disorders were significantly correlated to the gene expression profiles in the brain ( P = 1.1E-9) and pituitary gland ( P = 1.9E-6). Then, 61 protein-coding and non-coding genes were identified as effective genes in the pituitary gland ( P < 9.23E-6) and were enriched in metabolic pathways related to glutathione mediated arsenate detoxification and to D-myo-inositol-trisphosphate. Conclusion Here, we show that a negative genetic correlation exists between SCZ and T2DM at the whole genome, autosome, locus and causal variant levels. We identify pituitary gland as a common effective organ for both diseases, in which non-protein-coding effective genes, such as lncRNAs, may be responsible for the negative genetic correlation. This highlights the importance of molecular metabolism and neuroendocrine modulation in the pituitary gland, which may be responsible for the initiation of T2DM in SCZ patients.

Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis

Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes

Psychiatric Disorders and Type 2 Diabetes mellitus: A Bidirectional Mendelian Randomization

Shared familial risk for type 2 diabetes mellitus and psychiatric disorders: a nationwide multigenerational genetics study

Uncovering the genetic underpinnings for different psychiatric disorder combinations

Shared genetic architecture of psychiatric disorders and hemorrhoidal disease: a large-scale genome-wide cross-trait analysis

Evidence that the pituitary gland connects type 2 diabetes mellitus and schizophrenia based on large-scale trans-ethnic genetic analyses

Bidirectional Mendelian Randomization and Multiphenotype GWAS Show Causality and Shared Pathophysiology Between Depression and Type 2 Diabetes

Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

Unravelling the joint genetic architecture between psychiatric and insulin-related traits in the general population

A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome

Shared Genetic Architecture Between Eating Disorders, Mental Health Conditions, and Cardiometabolic Diseases: A Comprehensive Population-Wide Study Across Two Countries

Genomic insights into the comorbidity between type 2 diabetes and schizophrenia

Causal Relationship and Shared Genetic Loci between Psoriasis and Type 2 Diabetes through Trans-Disease Meta-Analysis

Investigating the shared genetic architecture between attention-deficit/hyperactivity disorder and risk taking behavior: A large-scale genomewide cross-trait analysis

Dissecting shared genetic architecture between depression and body mass index

Shared Genetics between Age at Menarche and Type 2 Diabetes Mellitus: Genome-Wide Genetic Correlation Study

Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis

Analysis of genetic differences between psychiatric disorders: Exploring pathways and cell-types/tissues involved and ability to differentiate the disorders by polygenic scores

The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity

Divergent patterns of genetic overlap between severe mental disorders and metabolic markers